South American Gold Corp. (SAGD)
South American Gold Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $67,735. On trailing twelve-month figures it carries a trailing P/E of -0.50, a net margin of -595.3%. Its beta of 0.38 implies it has historically moved less than the broad market.
As an operational management entity, South American Gold Corp (SAGD) is dedicated to maximizing shareholder returns. The company achieves this by developing and supplying essential products and support solutions for cannabis-related ventures. Its activities span both innovative technology and established physical goods, ensuring a broad spectrum of products and services.
South American Gold Corp. is most often compared with the following Healthcare names: